Scientists have developed a genetically engineered virus that triggers the immune system to hunt and destroy glioblastoma brain tumours ...
Isabelle Carnell-Holdaway, 17, has faced not one but two unrelenting threats to her life. Diagnosed at 11 months of age with cystic fibrosis, the progressive genetic disease that causes lung ...
Isabelle Carnell-Holdaway, 17, has faced not one but two unrelenting threats to her life. Diagnosed at 11 months of age with cystic fibrosis, the progressive genetic disease that causes lung ...
A new genetically engineered virus has delivered a one-two punch against advanced cancers in initial findings from a phase I trial. Researchers found that RP2 – a modified version of the herpes ...
This is read by an automated voice. Please report any issues or inconsistencies here. Cancer-fighting, genetically engineered herpes simplex virus has been shown to be an effective treatment for ...
A genetically modified version of the virus behind cold sores might one day help people who’ve run out of other options. A modified herpesvirus combined with an immunotherapy drug shrank or eliminated ...
Scientists have developed a tumour-killing virus that triggers the immune system to hunt and destroy aggressive glioblastoma, ...
A team led by investigators at Mass General Brigham and Dana-Farber Cancer Institute has shown that a single injection of an oncolytic virus—a genetically modified virus that selectively infects and ...
LONDON - Researchers say a genetically modified herpes virus is showing promise in fighting against a range of advanced cancers in early trial results. A team from The Institute of Cancer Research, ...
A phase II randomized trial of talimogene laherparepvec (T-VEC) oncolytic immunotherapy with or without radiotherapy for patients with cutaneous metastases from solid tumors. The incidence of ...
It's a new weapon in the arsenal of cancer fighting treatments: utilizing genetically modified viruses to invade cancer cells and destroy them from the inside. University of Louisville researcher ...
Isabelle Carnell-Holdaway, 17, has faced not one but two unrelenting threats to her life. Diagnosed at 11 months of age with cystic fibrosis, the progressive genetic disease that causes lung ...